Merck

@Merck

We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only. FLS: merck.us/3TKXNuZ

Rahway, NJ

Merck
@Merck
Oct 13
We’re presenting new data from our industry-leading #oncology pipeline and portfolio at this year’s ESMO Congress, including three presentations from pivotal Phase 3 trials in Presidential Symposia. Learn more about our commitment to advancing research across a range of cancer
00:00
5
Merck
@Merck
Oct 10
Today at #AAO2026, we’re presenting data from our Phase 2b/3 trial of an investigational drug in patients with diabetic macular edema (DME). Learn more: go.merck.com/~4ba
5
Merck
@Merck
Sep 30
Today we shared positive Phase 2b results evaluating our investigational anti-TL1A biologic in adults with moderate to severe hidradenitis suppurativa (HS). Learn more: go.merck.com/~73c
00:00
15
Merck
@Merck
Sep 25
Learn more about our latest update in #oncology: go.merck.com/~oolz4s
6
Merck
@Merck
Sep 25
In collaboration with @EisaiUS, we’re proud to announce today’s #FDA approval of a new combination treatment option for certain patients with advanced renal cell carcinoma, marking an important step forward for people living with #KidneyCancer. Learn more: go.merck.com/~nex
00:00
10